For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
1999
|
1998
|
|
Assets |
|
|
Current Assets |
$59,160
|
$47,958
|
Investments |
326,773
|
303,908
|
Assets Whose Use Is Limited |
1,208
|
1,239
|
Property, Plant, and Equipment, net |
210,499
|
200,255
|
Contributions Receivable, less current portion |
15,154
|
20,216
|
Other Assets |
3,848
|
3,236
|
Total Assets |
$616,642
|
$576,812
|
|
Liabilities and Net Assets |
|
|
Current Liabilities |
$66,528
|
$55,424
|
Long-Term Debt and Other Liabilities |
154,974
|
158,926
|
Net Assets |
|
|
Unrestricted |
230,048
|
203,747
|
Temporarily Restricted |
92,034
|
72,689
|
Permanently Restricted |
73,058
|
86,026
|
|
Subtotal Net Assets |
395,140
|
362,462
|
Total Liabilities and Net Assets |
$616,642
|
$576,812
|
|
Summary Statistical Information |
|
|
(Unless otherwise noted, includes adult and pediatric patients) |
1999
|
1998
|
Number of Licensed Beds (as of year end) |
34
|
34
|
Adult Inpatient Discharges |
956
|
869
|
Infusion Visits |
34,373
|
26,359
|
Outpatient MD Visits |
69,523
|
59,438
|
Clinical Trials (via Dana-Farber/Harvard Cancer Center) |
384
|
335
|
|
